Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Anne L Angiolillo"'
Autor:
Sumit Gupta, Yunfeng Dai, Zhiguo Chen, Lena E Winestone, David T Teachey, Kira Bona, Richard Aplenc, Karen R Rabin, Patrick Zweidler-McKay, Andrew J Carroll, Nyla A Heerema, Julie Gastier-Foster, Michael J Borowitz, Brent L Wood, Kelly W Maloney, Leonard A Mattano, Eric C Larsen, Anne L Angiolillo, Michael J Burke, Wanda L Salzer, Stuart S Winter, Patrick A Brown, Erin M Guest, Kimberley P Dunsmore, John A Kairalla, Naomi J Winick, William L Carroll, Elizabeth A Raetz, Stephen P Hunger, Mignon L Loh, Meenakshi Devidas
Publikováno v:
The Lancet Haematology. 10:e129-e141
Autor:
Reuven J. Schore, Anne L. Angiolillo, John A. Kairalla, Meenakshi Devidas, Karen R. Rabin, Patrick Zweidler-McKay, Michael J. Borowitz, Brent Wood, Andrew J. Carroll, Nyla A. Heerema, Mary V. Relling, Johann Hitzler, Nina S. Kadan-Lottick, Kelly Maloney, Cindy Wang, William L. Carroll, Naomi J. Winick, Elizabeth A. Raetz, Mignon L. Loh, Stephen P. Hunger
Publikováno v:
Leukemia.
Autor:
Aman Wadhwa, Yanjun Chen, Lindsey Hageman, Anna Hoppmann, Anne L Angiolillo, David Dickens, Glen Lew, Joseph P. Neglia, Yaddanapudi Ravindranath, Arthur K. Ritchey, Amanda Muench Termuhlen, Lennie Wong, Wendy Landier, Smita Bhatia
Publikováno v:
Blood. 140:2183-2184
Autor:
Rozalyn L Rodwin, John A Kairalla, Emily Hibbitts, Meenakshi Devidas, Moira K Whitley, Caroline E Mohrmann, Reuven J Schore, Elizabeth Raetz, Naomi J Winick, Stephen P Hunger, Mignon L Loh, Marilyn J Hockenberry, Anne L Angiolillo, Kirsten K Ness, Nina S Kadan-Lottick
Publikováno v:
J Natl Cancer Inst
Background Children with B-acute lymphoblastic leukemia (B-ALL) are at risk for chemotherapy-induced peripheral neuropathy (CIPN). Children’s Oncology Group AALL0932 randomized reduction in vincristine and dexamethasone (every 4 weeks vs 12 weeks d
Autor:
Radha Rohatgi, David A. Jacobsohn, Elizabeth Wells, Reuven J. Schore, Joshua Terao, Anne L. Angiolillo, Evelio Perez, Anant Vatsayan, Birte Wistinghausen, Hema Dave, Challice L. Bonifant, Alexandra Dreyzin
Publikováno v:
Pediatric hematology and oncology. 39(4)
Autor:
Samuel W. Brady, Kathryn G. Roberts, Zhaohui Gu, Lei Shi, Stanley Pounds, Deqing Pei, Cheng Cheng, Yunfeng Dai, Meenakshi Devidas, Chunxu Qu, Ashley N. Hill, Debbie Payne-Turner, Xiaotu Ma, Ilaria Iacobucci, Pradyuamna Baviskar, Lei Wei, Sasi Arunachalam, Kohei Hagiwara, Yanling Liu, Diane A. Flasch, Yu Liu, Matthew Parker, Xiaolong Chen, Abdelrahman H. Elsayed, Omkar Pathak, Yongjin Li, Yiping Fan, J. Robert Michael, Michael Rusch, Mark R. Wilkinson, Scott Foy, Dale J. Hedges, Scott Newman, Xin Zhou, Jian Wang, Colleen Reilly, Edgar Sioson, Stephen V. Rice, Victor Pastor Loyola, Gang Wu, Evadnie Rampersaud, Shalini C. Reshmi, Julie Gastier-Foster, Jaime M. Guidry Auvil, Patee Gesuwan, Malcolm A. Smith, Naomi Winick, Andrew J. Carroll, Nyla A. Heerema, Richard C. Harvey, Cheryl L. Willman, Eric Larsen, Elizabeth A. Raetz, Michael J. Borowitz, Brent L. Wood, William L. Carroll, Patrick A. Zweidler-McKay, Karen R. Rabin, Leonard A. Mattano, Kelly W. Maloney, Stuart S. Winter, Michael J. Burke, Wanda Salzer, Kimberly P. Dunsmore, Anne L. Angiolillo, Kristine R. Crews, James R. Downing, Sima Jeha, Ching-Hon Pui, William E. Evans, Jun J. Yang, Mary V. Relling, Daniela S. Gerhard, Mignon L. Loh, Stephen P. Hunger, Jinghui Zhang, Charles G. Mullighan
Publikováno v:
Nat Genet
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Here, using whole-genome, exome and transcriptome sequencing of 2,754 childhood patients with ALL, we find that, despite a generally low mutation burden, ALL cases harbor a media
Autor:
Melissa A. Richard, Meenakshi Devidas, Wenjian Yang, John P. Woodhouse, Vilmarie Rodriguez, Johann K. Hitzler, Reuven J. Schore, Anne L. Angiolillo, Michael J. Burke, Wanda L. Salzer, Elizabeth A. Raetz, Mignon L. Loh, Stephen P. Hunger, Jun J. Yang, Philip J. Lupo, Karen R. Rabin
Publikováno v:
Cancer Research. 82:2002-2002
Background: Children with Down syndrome (DS) have an increased risk of acute lymphoblastic leukemia (ALL) and are more likely to experience morbidity and mortality from infectious toxicities during treatment compared to those without DS. We sought to
Autor:
Etan Orgel, Olga Militano, Zhiguo Chen, Meenakshi Devidas, Luke Devon Maese, Rachel E. Rau, Anne L. Angiolillo, Jennifer Lynn McNeer, Reuven J. Schore, Elizabeth A. Raetz, Lewis B. Silverman, Naomi J. Winick, Eric Larsen, William L. Carroll, Stuart S Winter, Kimberley Dunsmore, Stephen Hunger, Mignon L. Loh
Publikováno v:
Journal of Clinical Oncology. 40:7000-7000
7000 Background: Asparaginase is integral to pediatric-inspired regimens (PIR) to treat acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYA). However, asparaginase-associated toxicities (AAT) often preclude delivery of planned the
Autor:
Mignon L. Loh, Johann K. Hitzler, Naomi J. Winick, Reuven J. Schore, Andrew J. Carroll, Ashley R. Lane, Brent L. Wood, Patrick A. Zweidler-McKay, Anne L. Angiolillo, Elizabeth A. Raetz, Nyla A. Heerema, Cindy Wang, Karen R. Rabin, Michael J. Borowitz, John A. Kairalla, Mary V. Relling, Meenakshi Devidas, William L. Carroll, Mylene Bassal, Kelly W. Maloney, Stephen P. Hunger
Publikováno v:
J Clin Oncol
Purpose: AALL0932 evaluated two randomized maintenance interventions to optimize disease-free survival (DFS) while reducing the burden of therapy in children with newly diagnosed NCI standard-risk (SR) B-acute lymphoblastic leukemia (B-ALL). Methods:
Autor:
Anne L. Angiolillo, Scott Raskin
Childhood cancer is an area of pediatric medicine with tremendous growth in identifying new biological and molecular markers for the diagnosis, monitoring, and treatment of disease. Although childhood cancer is still rare, data according to the Surve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1af9fe76e6a4e8081f859da00298820f
https://doi.org/10.1016/b978-0-12-817962-8.00020-2
https://doi.org/10.1016/b978-0-12-817962-8.00020-2